Argentina issued Wednesday, December 30 an "
emergency
"
authorization
for the vaccine developed by the British laboratory AstraZeneca and the University of Oxford, a few hours after the green light granted by the United Kingdom, announced the health authorities .
Read also: Covid-19: AstraZeneca / Oxford vaccine approved in the United Kingdom
The vaccine, for which Argentina has entered into a manufacturing agreement, has been entered in the “
register of vaccines of emergency health interest
” for a period of one year, the National Medicines Administration said.